(Q83474636)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350558%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

title

p53 stabilization induces apoptosis in chronic myeloid leukemia blast crisis cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350558%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

chronic myeloid leukemia

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350558%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

L F Peterson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350558%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

E Mitrikeska

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350558%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

D Giannola

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350558%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Y Lui

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350558%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

H Sun

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350558%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

D Bixby

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350558%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

S N Malek

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350558%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

N J Donato

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350558%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

M Talpaz

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350558%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

publication date

25 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350558%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350558%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350558%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350558%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

761-769

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350558%20AND%20SRC:MED&resulttype=core&format=json

Discovery of the Philadelphia chromosome: a personal perspective

23 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Chromosome translocations: dangerous liaisons revisited.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Jak2 is involved in c-Myc induction by Bcr-Abl

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

From mRNA metabolism to cancer therapy: chronic myelogenous leukemia shows the way.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Regulating the p53 pathway: in vitro hypotheses, in vivo veritas

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Molecular abnormalities in chronic myeloid leukemia: deregulation of cell growth and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

BCR/ABL activates mdm2 mRNA translation via the La antigen

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

p53 in health and disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

The p53 network: p53 and its downstream genes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Transcriptional control of human p53-regulated genes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

p53 has a direct apoptogenic role at the mitochondria

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

A system for stable expression of short interfering RNAs in mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

The Noxa/Mcl-1 axis regulates susceptibility to apoptosis under glucose limitation in dividing T cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

The multi-functional cellular adhesion molecule CD44 is regulated by the 8;21 chromosomal translocation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

High Bcr-Abl expression prevents the translocation of Bax and Bad to the mitochondrion

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

MDM2 inhibitors for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Activation of a novel Bcr/Abl destruction pathway by WP1130 induces apoptosis of chronic myelogenous leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Elevated MDM2 boosts the apoptotic activity of p53-MDM2 binding inhibitors by facilitating MDMX degradation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Cytochrome c: functions beyond respiration

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

The mitochondrial p53 pathway

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Noxa: at the tip of the balance between life and death.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Tyrosine phosphorylation and CD95: a FAScinating switch

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Tumor promoting effects of CD95 signaling in chemoresistant cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Translation of the Philadelphia chromosome into therapy for CML.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Mechanisms of resistance to STI571 in Philadelphia chromosome-associated leukemias

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Strategies for overcoming imatinib resistance in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+ CML cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Analysis of the p53 and MDM-2 gene in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Dual effect of p53 on radiation sensitivity in vivo: p53 promotes hematopoietic injury, but protects from gastro-intestinal syndrome in mice.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

p53 regulates hematopoietic stem cell quiescence.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Long-term haematopoietic reconstitution by Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Modulation of beta-catenin-mediated TCF-signalling in prostate cancer cell lines by wild-type and mutant p53.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Identification of Tcf-4 as a transcriptional target of p53 signalling

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021

Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.7

7 January 2021